Betticher DC - Search Results

1

Dacarbazine and interferon-alpha 2a in advanced malignant melanoma: high response rate and prolongation of response duration occur in different patient subpopulations.

Betticher DC, Lee SM, Morris C, Clemons M, Thatcher N. Betticher DC, et al. Melanoma Res. 1995 Aug;5(4):277-82. doi: 10.1097/00008390-199508000-00012. Melanoma Res. 1995. PMID: 7496165 Clinical Trial.

2

Melanoma: chemotherapy.

Lee SM, Betticher DC, Thatcher N. Lee SM, et al. Among authors: betticher dc. Br Med Bull. 1995 Jul;51(3):609-30. doi: 10.1093/oxfordjournals.bmb.a072982. Br Med Bull. 1995. PMID: 7552084 Review.

3

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.

Betticher DC, Anderson H, Ranson M, Meely K, Oster W, Thatcher N. Betticher DC, et al. Br J Cancer. 1995 Dec;72(6):1551-5. doi: 10.1038/bjc.1995.546. Br J Cancer. 1995. PMID: 8519676 Free PMC article. Clinical Trial.

4

Symptomatic benefit from gemcitabine and other chemotherapy in advanced non-small cell lung cancer: changes in performance status and tumour-related symptoms.

Thatcher N, Anderson H, Betticher DC, Ranson M. Thatcher N, et al. Among authors: betticher dc. Anticancer Drugs. 1995 Dec;6 Suppl 6:39-48. doi: 10.1097/00001813-199512006-00007. Anticancer Drugs. 1995. PMID: 8718424 Review.

5

Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.

Betticher DC, Heighway J, Thatcher N, Hasleton PS. Betticher DC, et al. Br J Cancer. 1997;75(12):1761-8. doi: 10.1038/bjc.1997.300. Br J Cancer. 1997. PMID: 9192978 Free PMC article.

6

Alternate splicing produces a novel cyclin D1 transcript.

Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Betticher DC, et al. Oncogene. 1995 Sep 7;11(5):1005-11. Oncogene. 1995. PMID: 7675441

7

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WD, Cerny T, Thatcher N. Betticher DC, et al. Br J Cancer. 1996 Feb;73(3):294-300. doi: 10.1038/bjc.1996.52. Br J Cancer. 1996. PMID: 8562333 Free PMC article.

8

G1 control gene status is frequently altered in resectable non-small cell lung cancer.

Betticher DC, White GR, Vonlanthen S, Liu X, Kappeler A, Altermatt HJ, Thatcher N, Heighway J. Betticher DC, et al. Int J Cancer. 1997 Oct 21;74(5):556-62. doi: 10.1002/(sici)1097-0215(19971021)74:5<556::aid-ijc14>3.0.co;2-4. Int J Cancer. 1997. PMID: 9355981

9

Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.

Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC. Vonlanthen S, et al. Among authors: betticher dc. Oncogene. 1998 Nov 26;17(21):2779-85. doi: 10.1038/sj.onc.1202501. Oncogene. 1998. PMID: 9840942

10

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies.

Laurencet FM, Zulian GB, Guetty-Alberto M, Iten PA, Betticher DC, Alberto P. Laurencet FM, et al. Among authors: betticher dc. Br J Cancer. 1999 Mar;79(7-8):1215-9. doi: 10.1038/sj.bjc.6690195. Br J Cancer. 1999. PMID: 10098762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters